LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.png)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。
Track-and-trace regulations around the world represent a complex and ever-evolving set of requirements based on where you operate and what sort of pharmaceuticals you manufacture, distribute or dispense. Read on to learn more.
Around the world, countries are introducing new legislation aimed at preventing counterfeit and harmful goods from entering the global supply chain. These new rules, necessary to boost public safety and confidence in global markets, show broad adoption of end-to-end traceability, embracing the notion that any single product should be fully traceable from its manufacturer down through distribution channels to retailers, health systems, pharmacies, and other public-facing businesses. However, such rules aren’t always easy to implement or follow. Some of these regulations outline systems, solutions, or methods of collaboration that have not been fully developed, are not immediately accessible to industry, or are difficult to roll out at-scale. Often, businesses struggle to understand their new responsibilities even as they commit staff hours to implementing them, a position that can incur additional costs and hurt productivity – without certainty of protection from regulatory penalties or reputational damage.
通过 LSPedia 探索美洲各地的药品法规。从具有里程碑意义的美国 DSCSA 到例外试点等,我们的综合资源中心可让您随时了解动态制药领域的合规标准。
借助LSPedia的专用资源中心,保持欧洲药品法规的领先地位。从欧盟口蹄疫到食品和烟草法规以及 EMVO SDK,我们的全面内容可确保在充满活力的欧洲市场中保持合规性。
LSPedia的亚太监管中心提供对韩国、中国和印度(CDSCO)药品法规的见解。利用我们全面的资源,在这些多元化的市场中保持合规。
我们很乐意听取你的意见!